Nocdurna (Desmopressin)

Desmopressin, the active ingredient in Nocdurna, is a vasopressin analog presented as a sublingual tablet for sublingual use. It treats central diabetes insipidus, nocturnal enuresis, and certain bleeding disorders such as mild hemophilia A by mimicking the natural hormone vasopressin, helping the kidneys retain water and supporting clotting factor release. The formulation is approved in the European Union and requires a prescription.

GNH USA supplies Nocdurna as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acts on the antidiuretic hormone pathway to manage conditions characterized by excessive urine production or bleeding.

- Central diabetes insipidus: reduces excessive urine output by increasing water reabsorption in the kidneys. - Nocturnal enuresis: decreases nighttime bedwetting episodes by concentrating urine. - Mild hemophilia A: enhances clotting factor VIII levels to aid hemostasis in mild bleeding disorders.

Desmopressin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Nasal congestion or dryness: due to sublingual administration. - Nausea: occasional gastrointestinal upset. - Hyponatremia: mild reduction in serum sodium. - Flushing: transient warmth or redness.

Serious or Rare Side Effects: - Severe hyponatremia: can lead to seizures or coma. - Water intoxication: excessive fluid retention causing edema. - Allergic reaction: rash, itching, or anaphylaxis. - Thrombotic events: rare clot formation. - Cardiovascular instability: hypotension or hypertension.

When prescribing desmopressin, clinicians should consider several safety precautions to minimize risk. - Assess renal function: adjust use in patients with impaired kidney clearance. - Monitor serum sodium: check levels regularly, especially in the elderly or those on diuretics. - Evaluate fluid intake: advise patients to limit excessive water consumption. - Review concomitant drugs: avoid concurrent use with other antidiuretic agents. - Pregnancy and lactation: use only if potential benefit outweighs risk, as safety data are limited. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Desmopressin can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Other antidiuretic agents (e.g., carbamazepine, chlorpropamide): risk of severe hyponatremia. - NSAIDs (e.g., ibuprofen, naproxen): may potentiate water retention and hyponatremia.

Moderate Interactions (Monitor Closely): - Diuretics (especially thiazides): increase risk of electrolyte imbalance. - Anticoagulants (e.g., warfarin): may enhance bleeding control, requiring monitoring. - SSRIs or SNRIs: potential additive effect on hyponatremia. - CYP450 inhibitors (e.g., erythromycin): may affect desmopressin metabolism modestly.